View All Key Stats
VVUS Key Stats
| Income Statement | |
| Revenue (TTM) | 133.40M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 0.31 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 32.97M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 68.20% |
| Profit Margin (Quarterly) | -119.2% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0.00 |
| Price and Valuation | |
| Market Cap | 102.11M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 0.7648 |
| PE Ratio (TTM) | 3.113 |
| Price to Book Value | 18.66 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 44.74 |
| Free Cash Flow (Quarterly) | -4.216M |
| Return on Equity (TTM) | -636.0% |
View All VVUS News
VVUS News
-
WireHeadlineTime (ET)
-
Yahoo09/08 08:00
-
Yahoo09/06 18:09
-
MT Newswires09/06 16:33
-
SA Breaking News09/06 16:23
-
Marketwired09/06 16:05
-
SA Breaking News09/05 11:10
-
MT Newswires09/05 09:30
-
Marketwired09/05 08:00
-
Yahoo09/04 08:29
-
PR Newswire09/01 06:55
View All Events
VVUS Events
| Date | Type | Description |
|---|---|---|
| 10/27/2017 | Misc | VIVUS Inc Annual General Meeting in 2016 |
| 08/03/2017 | Earnings | VIVUS Inc Second Quarter Earnings Results in 2017 |
| 05/03/2017 16:30 EDT | Misc | VIVUS Inc First Quarter Earnings Conference Call in 2017 |
| 05/03/2017 | Earnings | VIVUS Inc First Quarter Earnings in 2017 Release |
| 03/08/2017 16:30 EST | Misc | VIVUS Inc Fourth Quarter Earnings Conference Call in 2016 |
| 03/08/2017 | Earnings | VIVUS Inc Fourth Quarter Earnings in 2016 Release |
| 11/09/2016 16:30 EST | Misc | VIVUS Inc Third Quarter Earnings Conference Call in 2016 |
| 11/09/2016 | Earnings | VIVUS Inc Third Quarter Earnings in 2016 Release |
| 11/08/2016 | Misc | VIVUS Inc Annual General Meeting in 2015 |
VVUS Fundamentals
Income Statement View Statement
VVUS Ratings
Advertisement
VVUS One Page Reports
- One Page Report Download
VVUS Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Target Price | |
| Price | 0.965 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.vivus.com
- Investor Relations URL: http://ir.vivus.com/
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: Aug. 03, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: VIVUS Incis a biopharmaceutical company engaged in the development and commercialization of therapeutic products for large underserved markets. Its product line includes Qsymia for sleep apnea, STENDRA for erectile dysfunction.
VVUS Comparables
EditVVUS Excel Add-In Codes
- Name: =YCI("VVUS","name")
- Description: =YCI("VVUS","description")
- Sector: =YCI("VVUS","sector")
- Industry: =YCI("VVUS","industry")
- Est. Current Fiscal Year End: =YCI("VVUS","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other VVUS Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- VVUS Tweets Stocktwits
Advertisement
